MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    The PDCogniCare Toolkit: Developing a harmonised neuropsychological toolkit specific to Parkinson’s Disease

    E. Mccann, D. Pourzinal, D. Sriram, L. Mitchell, J. Liddle, A. Lehn, N. Dissanayaka (Herston, Australia)

    Objective: To critically evaluate neuropsychological measures predictive of cognitive decline in Parkinson’s disease (PD) with the aim of proposing a comprehensive, evidence-based neuropsychological toolkit specific…
  • 2025 International Congress

    Correlational Analysis between Anxiety and Self-perception of Health in Patients with and without Idiopathic Parkinson’s Disease without Dementia.

    S. Ospina Otalvaro, C. Alberto Hurtado-González, J. Felipe Ayala-Rico, P. Andrea Gutiérrez-Leni, A. Lucumi-Moreno, S. Cárdenas-Zuñiga, M. Cañas-Lucendo, D. Reyes-Torres, S. Ordoñez-Cure, A. Cubides-Munévar, E. Muñoz-Alvarez (Cali, Colombia)

    Objective: To analyze the impact of anxiety on self-perception of health in patients with Idiopathic Parkinson's Disease Without Dementia. Background: After depression in Idiopathic Parkinson's…
  • 2025 International Congress

    Integrating the Collaborative Care Mental Health Model into Virtual Parkinson’s Disease Care

    E. Ferluga, E. Anderson, N. Flanagan, D. Geraldi-Samara, J. Riser, K. Brendle (Chicago, USA)

    Objective: In Parkinson’s Disease (PD), neuropsychiatric symptoms start in the prodromal stage.  Increased rates of depression and anxiety in PD have been associated with living…
  • 2025 International Congress

    Investigating the use of Wearable Technologies as a Digital Biomarker for GBA1-Parkinson’s Disease

    N. Loefflad, M. Toffoli, E. Menozzi, A. Schapira (London, United Kingdom)

    Objective: This study evaluates if wearable sensors can detect prodromal motor features in non-manifesting GBA1 variant carriers (GBA-NMC). It also investigates if GBA1-PD patients exhibit…
  • 2025 International Congress

    Automatic quantification of motor symptoms including freezing of gait in Parkinson’s disease through motion capture

    W. Sako, M. Osawa, T. Iguchi, T. Hara, H. Haginiwa, S. Haji, N. Hattori (Bunkyo, Japan)

    Objective: The aim of this study was to quantify the motor symptoms of Parkinson's disease (PD), including freezing of gait, using a motion capture device.…
  • 2025 International Congress

    Alterations in Gait Initiation of subjects with Parkinson’s Disease: a comparative study with matched healthy controls

    D. Bonacina, D. Tosatto, A. Arrighetti, C. Perin, C. Alessandro, D. Piscitelli (Storrs, USA)

    Objective: To compare spatiotemporal, kinetic and kinematic variables of Gait Initiation (GI) between individuals with Parkinson’s disease (PD) and healthy controls (HC). Background: Balance and…
  • 2025 International Congress

    Clinical Features of Juvenile Parkinson Disease: a Comparative Study with Early-Onset Parkinson Disease

    L. Malfer, C. Piat, A. Mullan, K. Coffman, R. Savica (Rochester, USA)

    Objective: To describe a retrospective cohort of sixteen patients diagnosed with Juvenile Parkinson Disease and better define their family history, genetic profile, clinical progression, and…
  • 2025 International Congress

    Muscle Coactivation in subjects with Parkinson’s Disease: a Healthy-matched analysis of the Sub-Phases of Gait Cycle

    D. Bonacina, D. Tosatto, M. Leonardi, C. Perin, C. Alessandro, D. Piscitelli (Milano, Italy)

    Objective: To compare lower limb muscle coactivation (MC) during gait between Parkinson’s disease (PD) and healthy controls (HC). Background: MC increases with aging as a…
  • 2025 International Congress

    Parkinson’s Disease: Increased Presence of Neuropsychiatric Symptoms and Non-Motor Issues Drive Higher Medication Use and Costs

    S. Horn, E. Vaou, A. Parab, S. Wang, X. Pan, C. Yan, M. Shah, J. Jimenez-Shahed (San Antonio, USA)

    Objective: To compare neuropsychiatric disorders (NPsy), other non-motor symptoms (NMS), and associated medication use and costs in individuals with advanced Parkinson’s Disease (aPD) with those…
  • 2025 International Congress

    The influence of Caffeine intake on Type 2 Diabetes Mellitus mediated risk of Parkinson’s Disease.

    K. Mallavarapu, E. Tan (Singapore, Singapore)

    Objective: The objectives are to investigate if a diagnosis of Type 2 Diabetes Mellitus (T2DM) is associated with increased risk of developing Parkinson's Disease (PD)…
  • « Previous Page
  • 1
  • …
  • 94
  • 95
  • 96
  • 97
  • 98
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley